874-31989-86022
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 953 / CA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Moderna
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 2 — Moderna
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Asthenia, Chills, Diarrhoea, Feeling hot, Malaise, Nasal congestion, Pain, Self-medication — Feeling: Good · DiarrheaFree text: Symptoms began approx. 12 hours post injection (2nd Moderns shot at approx. 1125a, symptoms noticed approx. 11pm same day). Initial symptoms: chills/rigor, temp. 37.1 C. No injection site symptom/signs throughout. All symptoms, except 1, subsided by approx. 24hrs from onset. Exception of symptom ending: diarrhea; developed late, still present (BM consistency loose, BM frequency normal). From symptom onset, additional symptoms (Sx) developed: joint/body ache (low grade, constant), low energy/malaise, stuffy/hot nose sensation in nostrils. No nausea. Again all Sx, save noted, subsided approx. 24 hours post onset. Sx managed with 500 mg Acetaminophen 4-6 hrs until Sx abated.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Pain — Feeling: Good · Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: Body ache/fatigue subsided Sat. Mar 27 approx. 11pm. 2nd Shot 11a Fri. Mar 26. These symptoms (Sx) returned Mon. night/Tues. morning. Mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-17
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
-
2022-03-28
Survey response — 12 months, dose 2MedDRA: Depression, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Depression. · Healthcare visit (other): Appointment in May 2022 with Psychiatrist.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-29
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Moderna | |
| 2 | 2021-03-26 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Symptoms began approx. 12 hours post injection (2nd Moderns shot at approx. 1125a, symptoms noticed approx. 11pm same day). Initial symptoms: chills/rigor, temp. 37.1 C. No injection site symptom/signs throughout. All symptoms, except 1, subsided by approx. 24hrs from onset. Exception of symptom ending: diarrhea; developed late, still present (BM consistency loose, BM frequency normal). From symptom onset, additional symptoms (Sx) developed: joint/body ache (low grade, constant), low energy/malaise, stuffy/hot nose sensation in nostrils. No nausea. Again all Sx, save noted, subsided approx. 24 hours post onset. Sx managed with 500 mg Acetaminophen 4-6 hrs until Sx abated.
Systemic reaction (other): Body ache/fatigue subsided Sat. Mar 27 approx. 11pm. 2nd Shot 11a Fri. Mar 26. These symptoms (Sx) returned Mon. night/Tues. morning. Mild.
Release 11 — 12 months, dose 2
Symptoms: Depression.
Healthcare visit (other): Appointment in May 2022 with Psychiatrist.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Diarrhoea | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Malaise | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release